AstraZeneca and European Commission reach settlement agreement over vaccine supply, ending litigation Read more
Xeljanz receives marketing authorisation in EU to treat active polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis Read more
Novavax and European Commission finalise advance purchase agreement for up to 200 million doses of COVID-19 vaccine Read more